Lepu Biopharma Co., Ltd. (HKG:2157)

Hong Kong · Delayed Price · Currency is HKD

4.300

-0.220 (-4.87%)

Jul 30, 2026, 3:40 PM HKT

Lepu Biopharma Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	934.87	934.87	367.79	225.35	15.57	-
Revenue Growth	33.47%	154.18%	63.21%	1347.16%	-	-
Gross Profit	845.28	845.28	292.97	197.08	13.57	-
Operating Income	25.91	25.91	-395.84	-390.57	-642.45	-943.68
Net Income	261.36	261.36	-411.38	-22.1	-689.05	-1,011
Earnings Per Share	0.15	0.15	-0.24	-0.01	-0.42	-0.66
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
People's Republic of China (PRC)	571.08	571.08	345.83	101.39	15.57
Overseas	363.79	363.79	21.96	123.97	-
Total	934.87	934.87	367.79	225.35	15.57

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	959.78	959.78	475.99	498.43	678.2	214.24
Total Debt	1,064	1,064	850.16	746.82	690.3	335.26
Net Cash (Debt)	-104.05	-104.05	-374.17	-248.4	-12.1	-121.03
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.06	-0.06	-0.22	-0.15	-0.01	-0.08

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-12.23	-12.23	-196.39	-250.84	-480.93	-621.74
Capital Expenditures	-45.41	-45.41	-32.92	-28	-110.45	-213.39
Free Cash Flow	-57.64	-57.64	-229.31	-278.84	-591.38	-835.12
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	90.42%	90.42%	79.66%	87.45%	87.12%	-
Operating Margin	2.77%	2.77%	-107.62%	-173.32%	-4125.67%	-
Pretax Margin	27.88%	27.88%	-115.33%	-13.45%	-4491.66%	-
Profit Margin	27.96%	27.96%	-111.85%	-9.80%	-4424.94%	-
FCF Margin	-6.17%	-6.17%	-62.35%	-123.73%	-3797.71%	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	27.28	30.83	-	-	-	-
PS Ratio	7.84	8.62	11.45	28.14	692.84	-